Skip to content

Development of novel treatment strategies for spinal metastases and multi-center accelerated rehabilitation research during the perioperative period

Development of novel treatment strategies for spinal metastases and multi-center accelerated rehabilitation research during the perioperative period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079314
Enrollment
Unknown
Registered
2023-12-29
Start date
2024-01-10
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine metastases

Interventions

New treatment strategy and perioperative accelerated recovery group: Multidisciplinary accelerated recovery interventions based on a new treatment decision-making framework.
Control group:Use standard perioperative measures
Development of a novel decision-making framework for the treatment of spinal metastases:Not applicable
Construction and validation of a perioperative risk prediction model for spinal metastases based on machine learning algorithms:Not applicable

Sponsors

The Fourth Medical Centre of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age = 18 years; Imaging indicates ESCC 12-point grading as high or very high grade; presence of one or more of the following clinical manifestations: a. Local mechanical or radiating pain with progressive worsening. B. Progressive worsening of sensory dysfunction. C. Impairment of lower limb motor function. D. Impairment of sphincter function; expected survival time > 6 months.

Exclusion criteria

Exclusion criteria: Primary malignant tumors of the spine other than spinal myeloma; intramedullary metastasis of spinal metastatic tumors; the main spinal lesions have already undergone surgery or radiation therapy; combined with severe cardiovascular and cerebrovascular diseases, respiratory system diseases, severe infections, severe hepatic or renal insufficiency, severe coagulation disorders, severe psychological disorders, and other conditions where general anesthesia and surgery are not tolerable.

Design outcomes

Primary

MeasureTime frame
Intraoperative Blood Loss;Postoperative complications;

Secondary

MeasureTime frame
Postoperative walking function; The psychological health status of postoperative patients;Quality of life;Postoperative survival outcome;

Countries

China

Contacts

Public ContactYaosheng Liu

The Fourth Medical Centre of Chinese PLA General Hospital

liuyaosheng@301hospital.com.cn+86 158 1006 9346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026